Chaitali Tripathi

Bio:

Chaitali Tripathi?is a transformational clinical operations leader and currently serves as the Head of Study Readiness within Global Trial Strategy and Operations at Alnylam Pharmaceuticals. In her current role, she focuses on accelerating study start-up, enabling more predictable start-up outcomes, and driving operational scalability and robust documentation management across global programs. With over two decades of experience across pharma and biotech, Chaitali has led complex global clinical programs across multiple therapeutic areas, including immunology, neuroscience, oncology, and rare disease. She has contributed to strategic initiatives across the clinical operations landscape focused on improving execution, transparency, collaboration, and accountability across clinical development. Chaitali is passionate about building highly effective teams that drive both program and organizational success. She is committed to advancing operational excellence in clinical research keeping patient centricity and health equity always at the forefront.